Clinical Trials on Increase in Intracranial Pressure (ICP) in Hong Kong
Total 0 results
Nothing found
Sponsors and Collaborators
- Arsha Vidya Tirtha
- Cardiovascular Center Dedinje, Belgrade, Serbia
- Plethora Solutions Ltd
- Oblikue Consulting
- Foundation for Biosanitary Research and Innovation in Primary Health Care
- University of Applied Sciences Jena
- Foshan Sanshui District People's Hospital
- Eurotrials Brasil Consultores Cientificos Ltda
- Julian Taylor Green
- S-Biotek Holding ApS
- Rivierduinen, Centre for Personality disorders Jelgersma
- Lilly PharmaceuticalCompany
- Gunkang Pharmaceuticals, Inc
- United States Department of Defense (DOD)
- Paulo Sérgio Gomes Nogueira Borges
- 904 Hospital of the People's Liberation Army Joint Logistic Support Force
- Klinik für Allgemein- und Viszeralchirurgie, Department Chirurgie, Luzerner Kantonsspital
- Sudimplant SAS - Groupe TBR
- Iyad Naeem Muhammad, PhD
- Korea Otsuka International Asia Arab
- View Full List
Medical Conditions
- Chemotherapy-Induced Neutropenia
- Vibration; Exposure
- Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
- Malaria,Falciparum
- Serum Albumin Low
- Immunologically-induced Lung Disease
- Visual Attention Span Deficit
- Hypothermia Following Anesthesia, Sequela
- Brain Tumor, Primary
- Gray Platelet Syndrome
- Post-discharge Pharmacist Counseling to Prevent Readmissions
- Testicular Teratoma
- Huntington Chorea
- Thyroid and Parathyroid Surgery
- Deformity Flexion
- Advance Directive Completion
- Relapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma)
- Puberty, Delayed
- Blepharospasm of Both Eyelids
- Anemia Acute
- View Full List
Drug Interventions
- S-Adenosyl-Methionine
- Oxycodone
- Ebselen
- Standard medical therapy
- Furmonertinib 160 mg
- Acalabrutinib in combination with VR
- Vosaroxin
- Cytisine
- Pegfilgrastim
- Bimatoprost 0.03% eye drops
- Sorafenib
- Celecoxib
- Recombinant monoclonal antibody against human epidermal growth factor receptor injection (HS627)
- Cyanoacrylate
- MMV390048 120mg
- Rovalpituzumab tesirine
- Pemetrexed
- Mineralocorticoid receptor antagonist
- F520
- ABY-035 i.v.
- View Full List
CROs by country
- Contract Research Organizations in Brazil
- Contract Research Organizations in Ecuador
- Contract Research Organizations in Hungary
- Contract Research Organizations in Iran
- Contract Research Organizations in Japan
- Contract Research Organizations in Kazakhstan
- Contract Research Organizations in Malaysia
- Contract Research Organizations in Mauritius
- Contract Research Organizations in Myanmar
- Contract Research Organizations in Nigeria
- Contract Research Organizations in Poland
- Contract Research Organizations in Qatar
- Contract Research Organizations in United Kingdom
- CRO list by country